메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
김지현 (대구가톨릭대학교)
저널정보
대한생물치료정신의학회 생물치료정신의학 생물치료정신의학 제20권 제1호
발행연도
2014.4
수록면
24 - 34 (11page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Type 2 diabetes mellitus(T2DM) has been known to be a major risk factor for neurocognitive disorders including Alzheimer’s disease and vascular dementia. In this regard, insulin resistance is believed to be the central pathophysiology of T2DM-induced Alzheimer-like neurodegeneration and vascular impairment. Production of advanced glycation endproduct(AGE), excessive oxidative stress and consequent mitochondrial dysfunction, glutamate-related cytotoxicity, amyloid-β(Aβ) deposition, tau hyperphosphorylation, vascular endothelial injury, cytokine-induced inflammatory reactions and other disturbances in neural plasticity can be induced by insulin resistance and its related metabolic aberrations. These combined pathophysiologic mechanisms can result in structural deficits in brain regions including the prefrontal cortex and the hippocampus, which have been found to be related with neurocognitive functional declines in T2DM patients compared with non-T2DM controls. T2DM is also bidirectionally associated with higher prevalence of depression, and comorbid depression is related with a greater risk for development of dementia in T2DM patients. It has been shown that antidiabetic drugs are not just hypoglycemic agents, but also can be neuroprotective and even neurotherapeutic drugs in several preclinical trials. However, clinical results are controversial as yet. Further researches are required to precisely understand the aspect of metabolic brain dysfunction in T2DM and develop therapeutic guidelines for prevention and/or treatment of it.

목차

서론
본론
결론
참고문헌

참고문헌 (0)

참고문헌 신청

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2015-510-001452084